Stacy Grieve, PhD,  —

Synthetic Antimicrobial Peptide Can Destroy Biofilms in CF Patients, Study Reports

A therapy that involves a synthetic cationic antimicrobial peptide (CAP) can decrease Pseudomonas aeruginosa biofilm formation alone or in combination with another antimicrobial agent called tobramycin. Cystic fibrosis (CF) patients are susceptible to repeated bacterial infections. Infection with Pseudomonas aeruginosa (P. aeruginosa) is particularly harmful, since it has been shown to decrease…

PERT Dose Affects Weight Gain in Infants with Cystic Fibrosis, Study Finds

Cystic fibrosis is (CF) patients receiving higher doses of pancreatic enzyme replacement therapy (PERT) gain more weight, a recent report shows. PERT is a tablet that contains pancreatic enzymes. When taken with food, this therapy can improve the absorption of necessary nutrients. Many CF patients struggle with weight gain. This is…

Gaining Weight May Help CF Patients Delay the Worsening of Symptoms, Study Finds

A new study shows that weight gain during the treatment of acute worsening symptoms in patients with cystic fibrosis (CF), called pulmonary exacerbations, could possibly lengthen the period before symptoms worsen again. These results were published in the European Respiratory Journal Open Research, in an article titled, “…